Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
Abdulaziz Madani,1 Qais Almuhaideb2 1Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2College of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Abdulaziz MadaniKing Saud University, Riyadh, 11451, Saudi ArabiaTel +966 1-80 66481Fax +96...
Guardado en:
Autores principales: | Madani A, Almuhaideb Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b202cf0fa73d4d00a4effa0fecd8b8b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020) -
Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
por: Daham N, et al.
Publicado: (2020) -
FREQUENCY OF CLINICAL FEATURES AND CYTOGENETIC DEFECTS IN DOWN SYNDROME DIAGNOSED AT AFIP
por: Saira Irum, et al.
Publicado: (2021) -
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019) -
Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome
por: Erica Gastelum, et al.
Publicado: (2021)